X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs PIRAMAL ENTERPRISES - Comparison Results

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE PIRAMAL ENTERPRISES TTK HEALTHCARE/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 21.6 10.4 206.4% View Chart
P/BV x 7.3 1.8 403.2% View Chart
Dividend Yield % 0.4 0.9 44.2%  

Financials

 TTK HEALTHCARE   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
PIRAMAL ENTERPRISES
Mar-18
TTK HEALTHCARE/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs6633,083 21.5%   
Low Rs3991,902 21.0%   
Sales per share (Unadj.) Rs535.6589.7 90.8%  
Earnings per share (Unadj.) Rs15.9284.0 5.6%  
Cash flow per share (Unadj.) Rs20.0310.5 6.4%  
Dividends per share (Unadj.) Rs4.0025.00 16.0%  
Dividend yield (eoy) %0.81.0 75.1%  
Book value per share (Unadj.) Rs137.61,467.0 9.4%  
Shares outstanding (eoy) m7.77180.27 4.3%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x1.04.2 23.5%   
Avg P/E ratio x33.38.8 379.6%  
P/CF ratio (eoy) x26.58.0 330.4%  
Price / Book Value ratio x3.91.7 227.2%  
Dividend payout %25.18.8 285.0%   
Avg Mkt Cap Rs m4,127449,332 0.9%   
No. of employees `0001.76.8 25.0%   
Total wages/salary Rs m60719,881 3.1%   
Avg. sales/employee Rs Th2,436.715,535.6 15.7%   
Avg. wages/employee Rs Th355.22,905.4 12.2%   
Avg. net profit/employee Rs Th72.57,482.5 1.0%   
INCOME DATA
Net Sales Rs m4,162106,310 3.9%  
Other income Rs m612,595 2.4%   
Total revenues Rs m4,223108,906 3.9%   
Gross profit Rs m19751,599 0.4%  
Depreciation Rs m324,773 0.7%   
Interest Rs m3029,783 0.1%   
Profit before tax Rs m19719,638 1.0%   
Minority Interest Rs m02,801 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73-28,764 -0.3%   
Profit after tax Rs m12451,203 0.2%  
Gross profit margin %4.748.5 9.8%  
Effective tax rate %37.0-146.5 -25.3%   
Net profit margin %3.048.2 6.2%  
BALANCE SHEET DATA
Current assets Rs m1,629118,154 1.4%   
Current liabilities Rs m1,058462,260 0.2%   
Net working cap to sales %13.7-323.7 -4.2%  
Current ratio x1.50.3 602.4%  
Inventory Days Days3027 112.0%  
Debtors Days Days3447 72.2%  
Net fixed assets Rs m556113,727 0.5%   
Share capital Rs m78361 21.6%   
"Free" reserves Rs m878264,093 0.3%   
Net worth Rs m1,069264,454 0.4%   
Long term debt Rs m159242,206 0.1%   
Total assets Rs m2,399726,834 0.3%  
Interest coverage x7.61.7 456.7%   
Debt to equity ratio x0.10.9 16.2%  
Sales to assets ratio x1.70.1 1,185.9%   
Return on assets %6.411.1 57.5%  
Return on equity %11.619.4 59.8%  
Return on capital %18.510.3 179.0%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m3315,110 0.2%   
Fx outflow Rs m634,298 1.5%   
Net fx Rs m-3010,813 -0.3%   
CASH FLOW
From Operations Rs m127-159,666 -0.1%  
From Investments Rs m-146-17,677 0.8%  
From Financial Activity Rs m22186,503 0.0%  
Net Cashflow Rs m39,364 0.0%  

Share Holding

Indian Promoters % 65.4 52.9 123.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 4.0 92.5%  
FIIs % 5.2 26.6 19.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 16.5 156.4%  
Shareholders   12,723 93,274 13.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ABBOTT INDIA  NATCO PHARMA  BIOCON LTD  PFIZER  ALKEM LABORATORIES  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; Metal & Realty Stocks Gain(09:30 am)

Asian stock markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 1.2% while the Hang Seng is down 1%.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY19); Net Profit Down 152.5% (Quarterly Result Update)

Aug 1, 2018 | Updated on Aug 1, 2018

For the quarter ended June 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 1 bn (down 152.5% YoY). Sales on the other hand came in at Rs 29 bn (up 28.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Should You Buy These Mouthwatering High Dividend Stocks?(Profit Hunter)

Aug 1, 2018

Many stocks are yielding dividends even upwards of 4%-5%. Here are the kinds you should pick, and the ones to avoid.

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

NFO - Axis Equity Hybrid Fund: A Worthy Proposition?(Outside View)

Aug 1, 2018

PersonalFN explains if NFO: Axis Equity Hybrid Fund, would be a worthy proposition currently.

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Aug 14, 2018 12:13 PM

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS